首页> 外国专利> USE OF THE DIMERO OF LISOZIMA FOR THE MANUFACTURE OF A MEDICINAL PRODUCT TO MODULATE NATURAL DEFENSE MECHANISMS.

USE OF THE DIMERO OF LISOZIMA FOR THE MANUFACTURE OF A MEDICINAL PRODUCT TO MODULATE NATURAL DEFENSE MECHANISMS.

机译:使用利索美菌的狄美罗制造药物来调节自然防御机制。

摘要

THE INVENTION REFERS TO THE NEW USES OF THE DIMERIZED FORM OF THE LISOCIMA FOR THE MANUFACTURE OF A MEDICINAL PRODUCT TO INHIBIT THE BIOSINTESIS OF THE TUMOR NECROSIS FACTOR IN ANIMALS AND HUMANS. THE DIMERO OF LISOZYME IS, IN PARTICULAR, USEFUL FOR THE TREATMENT AND PROFILAXIS OF DISORDERS ASSOCIATED WITH EXCESSIVELY HIGH LEVELS OF TUMOR NECROSIS FACTOR. THE INVENTION ALSO REFERS TO PHARMACEUTICAL FORMULATIONS OF THE MEDICINAL PRODUCT ACCORDING TO THE INVENTION, IS TO SAY INJECTIONS THAT CONSIST OF THE DIMERIZED FORM OF THE LISOZYM IN QUANTITIES OF 0.01-10 MG / ML, OF AN APIROGENIC STERILE COMPOSITION THAT CONSISTS OF AT LEAST ONE PHYSIOLOGICALLY ACCEPTABLE AND AT LEAST A PHARMACEUTICALLY APPROVED PRESERVATIVE, ALSO AS ANOTHERPIC STAMPS AND ADVANTAGES IMPREGNATED WITH IT, AND POMADES OR GELS THAT CONSIST OF AN EFFECTIVE DOSE OF THE DIMERIZED FORM AND THE SEPARATION OF THE SEPARATION , ESPECIALLY OF INFECTED WOUNDS.
机译:本发明涉及利索昔(Lisocima)的数字化形式在制造医药产品方面的新用途,以抑制动物和人类的肿瘤坏死因子的生物增生。尤其是,Lisozyme的二聚体可用于治疗和增高与肿瘤坏死因子过高相关的疾病。本发明还涉及根据本发明的药物产品的药物配方,是指注射剂中至少包含0.01-10 MG / ML的脂溶酶的二聚体形式,该量的形式至少由至少一种无菌源性甾体组成组成生理上可接受的,并且至少在药物上认可的防腐剂,以及其上渗入的等价邮票和优势,以及构成有效剂量的二聚体或小凝胶,其形式和分离形式(尤其是分离的形式)有效。

著录项

  • 公开/公告号ES2074037T3

    专利类型

  • 公开/公告日2004-07-01

    原文格式PDF

  • 申请/专利权人 NIKA HEALTH PRODUCTS LIMITED;

    申请/专利号ES19930915903T

  • 发明设计人 KICZKA WITOLD;

    申请日1993-07-13

  • 分类号A61K38/46;C12N9/36;A61P37/04;A61P31/04;A61P31/12;

  • 国家 ES

  • 入库时间 2022-08-21 23:06:03

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号